首页 | 本学科首页   官方微博 | 高级检索  
     


Gene expression in implanted rat hepatocytes following retroviral-mediated gene transfer
Authors:Kathryn D. Anderson  John A. Thompson  Judith M. DiPietro  Kate T. Montgomery  Lola M. Reid  W. French Anderson
Affiliation:(1) Laboratory of Molecular Hematology, National Heart, Lung, and Blood Institute, National Institutes of Health, 20892 Bethesda, Maryland;(2) Department of Surgery, Children's Hospital National Medical Center, 20010 Washington, D.C.;(3) Present address: Genetic Therapy Inc., 19 Firstfield Road, 20878 Gaithersburg, Maryland;(4) Departments of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, 10461 Bronx, New York;(5) Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, 10461 Bronx, New York
Abstract:An hepatocyte transplantation-gene transfer protocol has been developed whereby liver cells containing an expressing NeoRgene can be successfully implanted in vivo. Adult primary cultures of rat hepatocytes, after infection with the retroviral vector N2, were grown on a floating solid support (coated with purified collagen IV) in a serum-free hormonally defined medium designed for hepatocytes that also contained G418. Under these conditions, normal adult hepatocytes expressing the NeoRgene could be grown to high density. The solid supports holding the gene-engineered hepatocytes were then implanted into adult rats into subcutaneous and intraperitoneal sites. After one to two weeks, the supports were removed and shown to still contain the gene-engineered hepatocytes expressing the NeoRgene. These results suggest that cells from solid organs, such as the liver, are potential targets for gene transfer and expression studies in vivo.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号